Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$0.42 - $0.72 $2,226 - $3,816
-5,300 Reduced 24.33%
16,482 $10,000
Q3 2023

Oct 24, 2023

BUY
$0.6 - $1.53 $2,012 - $5,131
3,354 Added 18.2%
21,782 $13,000
Q2 2023

Jul 25, 2023

BUY
$1.05 - $1.63 $456 - $709
435 Added 2.42%
18,428 $20,000
Q1 2023

Apr 14, 2023

SELL
$1.2 - $2.73 $98 - $223
-82 Reduced 0.45%
17,993 $24,000
Q4 2022

Feb 08, 2023

BUY
$1.71 - $3.61 $2,233 - $4,714
1,306 Added 7.79%
18,075 $33,000
Q3 2022

Oct 25, 2022

BUY
$1.9 - $8.63 $4,461 - $20,263
2,348 Added 16.28%
16,769 $41,000
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $3,857 - $16,317
1,811 Added 14.36%
14,421 $35,000
Q1 2022

May 11, 2022

BUY
$6.28 - $15.59 $6,418 - $15,932
1,022 Added 8.82%
12,610 $101,000
Q4 2021

Feb 08, 2022

SELL
$14.7 - $28.67 $492,626 - $960,789
-33,512 Reduced 74.31%
11,588 $177,000
Q3 2021

Nov 02, 2021

BUY
$24.31 - $33.6 $471,905 - $652,243
19,412 Added 75.57%
45,100 $1.28 Million
Q2 2021

Aug 11, 2021

SELL
$26.09 - $40.4 $115,630 - $179,052
-4,432 Reduced 14.71%
25,688 $866,000
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $76,963 - $132,533
-2,328 Reduced 7.17%
30,120 $1.15 Million
Q4 2020

Feb 12, 2021

BUY
$39.09 - $57.4 $486,631 - $714,572
12,449 Added 62.25%
32,448 $1.36 Million
Q3 2020

Nov 04, 2020

SELL
$28.43 - $44.67 $330,242 - $518,886
-11,616 Reduced 36.74%
19,999 $867,000
Q2 2020

Jul 17, 2020

BUY
$11.71 - $30.29 $154,794 - $400,403
13,219 Added 71.86%
31,615 $958,000
Q1 2020

Apr 21, 2020

BUY
$7.64 - $27.5 $6,921 - $24,915
906 Added 5.18%
18,396 $251,000
Q4 2019

Feb 12, 2020

BUY
$15.02 - $20.57 $58,202 - $79,708
3,875 Added 28.46%
17,490 $282,000
Q3 2019

Nov 07, 2019

BUY
$18.85 - $27.5 $7,163 - $10,450
380 Added 2.87%
13,615 $262,000
Q2 2019

Aug 06, 2019

BUY
$17.37 - $26.27 $229,891 - $347,683
13,235 New
13,235 $311,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.